Company Filing History:
Years Active: 2025
Title: Vikram Mitra: Innovator in Alzheimer's Disease Research
Introduction
Vikram Mitra is a notable inventor based in Cobham, GB. He has made significant contributions to the field of neurocognitive disorders, particularly in relation to Alzheimer's disease. His innovative work focuses on the identification and application of biomarkers that can aid in the diagnosis and treatment of this debilitating condition.
Latest Patents
Vikram Mitra holds a patent related to biomolecules involved in Alzheimer's disease. The invention pertains to panels of biomarkers, including proteins phosphatase 1 regulatory subunit 14A and/or 2',3'-cyclic-nucleotide 3'-phosphodiesterase and/or phosphorylated tau or fragments thereof. These biomarkers are crucial for diagnosing, staging, treating, and assessing the response to treatment for neurocognitive disorders characterized by tau toxicity, specifically Alzheimer's disease. The patent demonstrates that the biomarkers disclosed are elevated in the brains of subjects with advanced stages of the disorder and are regulated in the cerebrospinal fluid of Alzheimer's patients compared to cognitively affected non-Alzheimer's controls.
Career Highlights
Vikram Mitra is associated with Electrophoretics Limited, where he continues to advance research in the field of Alzheimer's disease. His work has garnered attention for its potential to improve diagnostic and therapeutic strategies for neurocognitive disorders.
Collaborations
Some of Vikram Mitra's notable coworkers include Ian Hugo Pike and Malcolm Andrew Ward. Their collaborative efforts contribute to the ongoing research and development in the field of Alzheimer's disease.
Conclusion
Vikram Mitra's innovative contributions to Alzheimer's disease research highlight the importance of biomarker identification in the diagnosis and treatment of neurocognitive disorders. His work continues to pave the way for advancements in understanding and managing this complex condition.